Byrne Wallace Shields LLP‘s intellectual property team assists in a range of contentious and non-contentious IP mandates, including brand and design protection. Considered a go-to for clients in the life sciences sector, Colin Sainsbury leads the non-contentious IP offering and regularly drafts and negotiates licensing, supply and service agreements.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘Personal attention to detail and responsiveness makes this team unique.’
'Excellent to deal with good communication and easy to understand.'
'Colin Sainsbury is a long standing and well renowned professional.'
‘Jane O'Grady is clearly a subject matter expert in the Intellectual Property domain and all my questions were comprehensively answered. Jane also adopts a commercial pragmatic approach which is especially helpful.’
‘Strong teamwork and culture. Good coordination amongst partners in terms of responding to client queries.’
Key clients
Starbucks Corporation
Headstuff Podcasts
Corpay
Suil Vision
UltraGreen.ai/Renew Pharma
Neuromod Devices Limited
Priothera Limited
Xeolas Pharmaceuticals Limited
Versono Medical Limited
Warburton Technology
European Circular Bioeconomy Fund
Q3 Medical Devices Limited
Work highlights
Advising MVM Partners (the lead investor) and OrbiMed in relation to the announced $80m Series B financing of ProVerum Limited
Advising StatisticaMedica on the negotiation and successful conclusion of a number of complex master services agreements with multinational life sciences companies.